» Articles » PMID: 29221595

Genetic and Environmental Risk Factors for Rheumatoid Arthritis

Overview
Publisher Elsevier
Specialty Rheumatology
Date 2017 Dec 10
PMID 29221595
Citations 243
Authors
Affiliations
Soon will be listed here.
Abstract

Multiple genetic and environmental factors have been associated with an increased risk for rheumatoid arthritis (RA). Of these, the strongest associations have been seen with female sex, a family history of RA, the genetic factor the "shared epitope," and exposure to tobacco smoke. There is also renewed interest in mucosal inflammation and microbial factors as contributors to the development of RA. However, the identification of a "preclinical" period of RA that can be defined as local or systemic autoimmunity as measured by autoantibodies and other biomarkers prior to the development of clinically apparent synovitis suggests that the risk factors for RA are acting long prior to first clinical evidence of IA. As such, a major challenge to the field will be to investigate the full spectrum of the development of RA, from initiation and propagation of autoimmunity during preclinical RA and transition to clinically apparent synovitis and classifiable RA, to determine which genetic and environmental factors are important at each stage of disease development. Understanding the exact role and timing of action of risk factors for RA is especially important given the advent of prevention trials in RA, and the hope that a full understanding of genetic and environmental factors in RA could lead to effective preventive interventions.

Citing Articles

Association of human blood metabolites with rheumatoid arthritis: A Mendelian randomization study.

Yan D, Luo D, Yan W, Liu H, Li J Medicine (Baltimore). 2025; 104(10):e41666.

PMID: 40068064 PMC: 11902995. DOI: 10.1097/MD.0000000000041666.


Update on tocilizumab in rheumatoid arthritis: a narrative review.

Parisi S, Ditto M, Ghellere F, Panaro S, Piccione F, Borrelli R Front Immunol. 2025; 16:1470488.

PMID: 40066438 PMC: 11891176. DOI: 10.3389/fimmu.2025.1470488.


Navigating interstitial lung disease associated with rheumatoid arthritis (RA-ILD): from genetics to clinical landscape.

Bernardinello N, Zen M, Castelli G, Cocconcelli E, Balestro E, Borie R Front Med (Lausanne). 2025; 12:1542400.

PMID: 40066169 PMC: 11891064. DOI: 10.3389/fmed.2025.1542400.


Biomaterials for Modulating the Immune Microenvironment in Rheumatoid Arthritis.

Wang Q, Ji J, Huang D, Gao C BME Front. 2025; 6:0102.

PMID: 40065832 PMC: 11893043. DOI: 10.34133/bmef.0102.


New Dawn in the Treatment of Rheumatoid Arthritis: Advanced Insight into Polymer Hydrogel Research.

Wang S, Li J, Ren F, Zhang J, Song W, Ren L Gels. 2025; 11(2).

PMID: 39996679 PMC: 11855332. DOI: 10.3390/gels11020136.


References
1.
de Jong H, Klungel O, van Dijk L, Vandebriel R, Leufkens H, van der Laan J . Use of statins is associated with an increased risk of rheumatoid arthritis. Ann Rheum Dis. 2011; 71(5):648-54. DOI: 10.1136/ard.2011.155622. View

2.
Arkema E, Karlson E, Costenbader K . A prospective study of periodontal disease and risk of rheumatoid arthritis. J Rheumatol. 2010; 37(9):1800-4. PMC: 2947828. DOI: 10.3899/jrheum.091398. View

3.
Bos W, Ursum J, de Vries N, Bartelds G, Wolbink G, Nurmohamed M . The role of the shared epitope in arthralgia with anti-cyclic citrullinated peptide antibodies (anti-CCP), and its effect on anti-CCP levels. Ann Rheum Dis. 2008; 67(9):1347-50. DOI: 10.1136/ard.2008.089953. View

4.
Frisell T, Saevarsdottir S, Askling J . Family history of rheumatoid arthritis: an old concept with new developments. Nat Rev Rheumatol. 2016; 12(6):335-43. DOI: 10.1038/nrrheum.2016.52. View

5.
Lenz T, Deutsch A, Han B, Hu X, Okada Y, Eyre S . Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases. Nat Genet. 2015; 47(9):1085-90. PMC: 4552599. DOI: 10.1038/ng.3379. View